3-iodobenzylguanidine has been researched along with edetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aalders, M; Beijnen, JH; Essers, M; Kuin, A; Lamfers, M; Smets, LA; van Zuidam, DJ | 1 |
| Cao, YM; François, F; Patrick, J | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and edetic acid
| Article | Year |
|---|---|
Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
Topics: 3-Iodobenzylguanidine; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Chlorambucil; Chromium Radioisotopes; Doxorubicin; Drug Synergism; Edetic Acid; Glucose; Guanidines; Hydrogen-Ion Concentration; Kidney; Leukemia L1210; Melphalan; Mice; Mitomycin; Tumor Cells, Cultured | 1999 |
Long-term prognostic value of analysis of sympathetic drive by myocardial 123I-metaiodobenzylganidine scintigraphy in chronic heart failure.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aprotinin; Brain; Echocardiography; Edetic Acid; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Natriuretic Peptides; Prognosis; Prospective Studies | 2010 |